Cetuximab MMAE Antibody
Cetuximab-MMAE is an EGFR-targeting antibody-drug conjugate (ADC) for research into colorectal and head and neck cancers. It delivers the cytotoxic agent MMAE to tumor cells and is utilized in both in vitro cytotoxicity assays and in vivo xenograft studies to evaluate targeted therapeutic efficacy.
Product Specifications
Target
Antibody-Drug Conjugates (ADCs), Microtubule Associated, EGFR
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Molecular Weight
150 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog